Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Cut to "Buy" at Vetr Inc

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Cut to

Price targets show what analysts believes a stock will be worth at the end of a certain time period. A P/B ratio of less than 1.0 can indicate that a stock is undervalued, while a ratio of greater than 1.0 may indicate that a stock is overvalued.

In the most updated research from a number of analysts on Wall Street, the company gets 17 Buys and 0 Sell among 22 analysts.

Currently, 0.20% shares of The Estee Lauder Companies Inc. Zacks Investment Research cut Vertex Pharmaceuticals from a "buy" rating to a "hold" rating in a research note on Friday, August 4th. Vertex Pharmaceuticals Incorporated has been given an analysts' mean target of 178.09. The stock closing price is now trading downward to its 50 day moving average with change of -5.96%, tumbled to its 20 day moving average with figure of -2.50% and behind its 200 day moving average with value -17.78%. Six equities research analysts have rated the stock with a hold rating and twenty-two have issued a buy rating to the company's stock.

Shares of Vertex Pharmaceuticals Incorporated (NASDAQ VRTX) opened at 157.215 on Tuesday. The overall volume in the last trading session was 9.1 million shares. Over the last five days, shares have faced -2.73% losses and now is up 41.27% since hitting its 200-day moving average of $125.51. The company has market cap of $40.04 billion. Vertex Pharmaceuticals has a 52-week low of $71.46 and a 52-week high of $167.85.

Vertex Pharmaceuticals Incorporated (VRTX) now has a Return on Assets (ROA) value of 8.8 Percent. The Return on Investment (ROI) ratio of Vertex Pharmaceuticals Incorporated (VRTX) is -0.3 percent. The company had revenue of $544.10 million for the quarter, compared to analysts' expectations of $489.95 million. The Regal Investment Advisors Llc holds 46,487 shares with $4.85M value, down from 50,297 last quarter. On average, analysts predict that Vertex Pharmaceuticals will post $1.60 EPS for the current fiscal year.

Sowell Financial Services LLC now owns 2,762 shares of the pharmaceutical company's stock worth $325,000 after acquiring an additional 23 shares in the last quarter. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of United States & worldwide trademark & copyright legislation. The correct version of this story can be accessed at Finally, Morgan Stanley increased its stake in shares of Vertex Pharmaceuticals by 269.3% in the third quarter. The share price has moved forward from its 20 days moving average, trading at a distance of 1.95% and stays 5.92% away from its 50 days moving average. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The shares were sold at an average price of $90.00, for a total transaction of $108,720.00. The disclosure for this sale can be found here. Also, EVP Stuart A. Arbuckle sold 1,208 shares of the company's stock in a transaction that occurred on Wednesday, November 9th.

Several large investors have recently modified their holdings of the stock. Guardian Life Insurance Co. of America lifted its position in shares of Vertex Pharmaceuticals by 0.6% during the first quarter. Baillie Gifford & Co. grew its holdings in shares of Vertex Pharmaceuticals by 6.9% during the second quarter. The earnings per share (EPS) term represents portion of a company's earnings with net of taxes as well as preferred stock dividends that is owed to each share of common stock. Vanguard Group Inc. raised its holdings in Vertex Pharmaceuticals by 3.5% during the 1st quarter. Jennison Associates LLC now owns 5,055,122 shares of the pharmaceutical company's stock valued at $651,454,000 after buying an additional 3,626,368 shares during the period. Finally, RNC Capital Management LLC boosted its holdings in Vertex Pharmaceuticals by 5.3% in the second quarter. Tocqueville Asset Management L.P. purchased a new position in shares of Vertex Pharmaceuticals in the 2nd quarter valued at about $203,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company.

Vertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing and commercializing medicines for serious diseases. Its business is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs in other indications.

Like this


13 September 2017
Janet Jackson's Brother Claims Wissam Al Mana 'Verbally Abused' Her During Marriage
Still, in a statement delivered to People , Al Mana's team claimed Randy's statements were false and completely inflammatory. Al Mana's attorney has addressed Randy's abuse allegations saying that they are untrue. "I didn't want them to know".

13 September 2017
Target hiring thousands for holiday season
Target is hiring more than 100,000 temporary workers for the holidays - a sharp increase over past year . Hiring events for store positions will be held at each of Target's 1,816 stores from 10 6 p.m.

13 September 2017
Which insiders are trading TETRA Technologies, Inc. (TTI)?
Their average price target spell out an upbeat performance - a 104% and would give TTI a market capitalization of almost $502.13M. Paloma Ptnrs Management Co owns 38,026 shares. (NYSE:SE) has "Outperform" rating given on Monday, June 27 by RBC Capital Markets.

13 September 2017
Does NGL Energy Partners LP (NGL)'s current closing price competes the market?
The investment managers in our partner's database now hold: 69.69 million shares, up from 67.69 million shares in 2016Q3. NGL Energy Partners LP (NYSE: NGL)'s market cap, the total dollar value of all of their outstanding shares, is 1105.56m.

13 September 2017
Budget for body probing Duterte drugs war slashed to just $25
Human rights monitors said the CHR was a vital institution that stands no chance of doing its job without a proper budget. "Mr. Congressman Edcel Lagman said 32 minority lawmakers opposed the measure during the debate at the second reading.

13 September 2017
Raveena Tandon VS Anil Kapoor In The Battle For The Hairiest Chest
Raveena and Anil have worked together in several films, including Laadla, Gharwali Baharwali and Bulandi , among others. The director-choreographer shared pictures from the sets and one of them is just hilarious.

13 September 2017
2 in USA TODAY NFL power rankings
The Patriots got slapped on Thursday night by the Chiefs, losing 42-27 and showed a real weakness against the run on defense. Astonishingly, Dallas didn't allow Eli Manning and the Giants to cross their own 35-yard line until the second half.

13 September 2017
Thousands without power in coastal Georgia from severe storm
Forrest and his roommate chose to ignore a mandatory evacuation order and ride out the storm in their apartment. The state has few refineries of its own and tankers and barges will have to deliver virtually all of its fuel.

13 September 2017
Should You Buy Finisar Corporation (NASDAQ:FNSR) On Current Analyst Views?
Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Lastly, Ameritas Investment Partners increased its position in stocks of Finisar Corporation by 5.5% in the 2nd period.

13 September 2017
Hurricane Irma's massive flooding and destruction in 25 photos
() - When it comes to hurricanes, Florida may as well have a target on its back. "But I thought we would see more damage". The figure represents nearly 60% of the state's electricity users, who were still experiencing power outage as of 9 p.m.